Product Program year 2020 Source: CMS Open Payments

iStent inject Trabecular Micro-Bypass Stent System

Device Glaucoma

Open in the dashboard

General payments

$1,628,328

6,402 payments

Research payments

$588,727

229 payments

Through program year 2020, $1,628,328 in general payments and $588,727 in research payments were reported against iStent inject Trabecular Micro-Bypass Stent System (Glaucoma).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $643,013 2,118
2020 Research $424,369 143
2019 General $985,315 4,284
2019 Research $164,358 86

Breakdown

Who paid General payments · program years 2019–2020
  1. Glaukos Corporation $1,628,328 6,402 payments
Top recipients General payments · program year 2020
  1. Oluwatosin Smith Ophthalmology · Dallas, TX $90,000 14% · 12 payments
  2. Kuldev Singh Ophthalmology · Stanford, CA $57,144 9% · 6 payments
  3. Barbara Smit Ophthalmology · Spokane, WA $33,000 5% · 11 payments
  4. Eric Donnenfeld Ophthalmology · Garden City, NY $30,124 5% · 4 payments
  5. Edward Holland Ophthalmology · Edgewood, KY $30,000 5% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Ophthalmology $504,129 82% · 835 practitioners
  2. Optometrist $48,264 8% · 501 practitioners
  3. Glaucoma Specialist Ophthalmology $38,108 6% · 37 practitioners
  4. Retina Specialist Ophthalmology $18,895 3% · 16 practitioners
  5. Optometrist, Corneal and Contact Management Optometrist $3,662 <1% · 18 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $142,394 22% · 259 recipients
  2. Texas $111,445 17% · 134 recipients
  3. New York $35,838 6% · 45 recipients
  4. Kentucky $33,445 5% · 11 recipients
  5. Washington $33,235 5% · 11 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

6,402 general · 229 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record